
IndraLab
Statements
reach
"The AURKA activator TPX2, is overexpressed in many cancers, and through AURKA binding, allosteric modulation, and protection of the T288 phosphorylation site from dephosphorylation, TPX2 increases AURKA levels and maintains its active state, augmenting AURKA oncogenic effects in the cell ."
sparser
"For organelle localization the major processes affected are organelle localization (logP = − 3.8), microtubule-based processes (logP = − 3.5), loss of Nlp from mitotic centrosomes (logP = − 3.4), AURKA activation by TPX2 (logP = − 3.4), centrosome maturation (logP = − 3.2), regulation of PLK1 activity at G2/M transition (logP = − 3.1), and recruitment of NuMa to mitotic centrosome (logP = − 2.9) ( Supplementary Table xref )."